PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pulmonary and Critical Care Medicine, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.\', \'Department of Respiratory Medicine, Sir Run Run Hospital, Nanjing Medical University, Nanjing, China.\', \'Department of Nephrology, Huangshi Hospital of Traditional Chinese Medicine, Huangshi, China.\', \'Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.\', \'Department of Critical Care Medicine, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.\', \'Jiangsu Cell Tech Medical Research Institute, Nanjing, China.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1089/scd.2021.0015
?:doi
?:hasPublicationType
?:journal
  • Stem cells and development
is ?:pmid of
?:pmid
?:pmid
  • 34044609
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.426
?:rankingScore_hIndex
  • 94
?:title
  • Human Umbilical Cord Mesenchymal Stromal Cell Treatment of Severe COVID-19 Patients: A 3-Month Follow-Up Study Following Hospital Discharge.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all